DUBLIN--(BUSINESS WIRE)--Sep 4, 2018--Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the following conference:

Morgan Stanley 16 th Annual Global Healthcare Conference

Date: Sept. 13, 2018 Presentation Time: 10:35 a.m. ET Location: New York, NY

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.

About Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com, follow us @HZNPplc on Twitter or like us on Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180904005080/en/

CONTACT: Horizon Pharma

Investors:

Tina Ventura

Senior Vice President,

Investor Relations

investor-relations@horizonpharma.com

or

Ruth Venning

Executive Director,

Investor Relations

investor-relations@horizonpharma.com

or

U.S. Media:

Geoff Curtis

Executive Vice President,

Corporate Affairs & Chief Communications Officer

media@horizonpharma.com

or

Ireland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

KEYWORD: UNITED STATES EUROPE NORTH AMERICA NEW YORK IRELAND

INDUSTRY KEYWORD: HEALTH PROFESSIONAL SERVICES FINANCE GENERAL HEALTH

SOURCE: Horizon Pharma plc

Copyright Business Wire 2018.

PUB: 09/04/2018 08:00 AM/DISC: 09/04/2018 08:01 AM

http://www.businesswire.com/news/home/20180904005080/en